
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Debt - Celcuity on 2025-09
Biotechnology • Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that comprehensively block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead product candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor in late-stage clinical development (including Phase 3 VIKTORIA trials) for HR+/HER2- advanced breast cancer and other indications such as prostate cancer. The company advances a focused pipeline of PAM pathway inhibitors, publishes clinical data, engages with investors and regulators, and is mission-driven to improve outcomes for cancer patients.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Debt - Celcuity on 2025-09
Biotechnology • Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that comprehensively block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead product candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor in late-stage clinical development (including Phase 3 VIKTORIA trials) for HR+/HER2- advanced breast cancer and other indications such as prostate cancer. The company advances a focused pipeline of PAM pathway inhibitors, publishes clinical data, engages with investors and regulators, and is mission-driven to improve outcomes for cancer patients.
• Support the Head of National Accounts & Field Reimbursement in developing and implementing strategic access initiatives with payer accounts (Commercial, Medicare, Medicaid) • Assist with the preparation and execution of cross-functional account plans and presentations for payer customers • Lead field reimbursement support for field-based teams’ in specific sales regions post-approval • Partner with Sales to equip team with clear, compliant payer and reimbursement messaging • Coordinate field reimbursement activities and support resources to resolve coverage, coding, and payment issues post-approval • Help organize executive-level payer meetings and follow-up communications across internal stakeholders • Assist with the development and refinement of reimbursement and payer materials, including value dossiers and payer slide decks • Monitor account-level activity and support execution against timeline, performance, and reporting objectives • Track and analyze relevant market trends and policy changes to inform payer strategy execution • Collaborate closely with internal partners to maintain consistent messaging and seamless customer experience • Act as a conduit between the field and leadership by sharing payer insights and competitive intelligence
• B.S. degree with minimum 8+ years of pharmaceutical/biotech industry experience, including 5+ years in Market Access, National Accounts, or Field Reimbursement • Familiarity with U.S. payer systems including Commercial, Medicare, and Medicaid • Experience supporting oncology products (IV and/or oral) • Proven ability to manage multiple priorities and work cross-functionally • Strong communication, project management, and analytical skills • Deep understanding of UP Payer trends and established executive relationships with National/Regional and Commercial/Government plans • Minimum of 5 years of Oncology experience • Oral and IV experience • Demonstrated teamwork and leadership including the ability to influence without positional authority • Effective and agile decision making and problem-solving skills • Excellent analytical skills and ability to effectively utilize available market data to understand all aspects of the market access channel landscape • Superior written, oral, and group communication skills • Must understand US pharmaceutical operations, healthcare and reimbursement landscape • Proven success in developing executive level approval of contract business cases including the rigorous financial analytics
• Medical, dental, and vision insurance • 401(k) match • Paid time off • Paid holidays • Annual performance incentive bonus • New hire equity package
Apply Now🔥 17 hours ago
Director for Centralized Statistical Monitoring at Amgen overseeing CSM analysis and leadership roles. Focusing on innovative methodologies and ensuring compliance with regulatory standards in clinical trials.
🇺🇸 United States – Remote
💵 $200.1k - $270.7k / year
💰 $28.5G Post-IPO Debt on 2022-12
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 20 hours ago
Director of Field Services responsible for driving operational excellence in field services across various markets. Leading performance frameworks to maximize client outcomes and team effectiveness.
🔥 21 hours ago
Global Business Unit Director responsible for managing a large hyperscale customer in Cloud solutions. Collaborating with teams for sales, program management, and customer satisfaction.
🇺🇸 United States – Remote
💰 $660.4M Post-IPO Debt on 2021-09
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 21 hours ago
51 - 200
IP attorney managing global intellectual property portfolio and advising on corporate strategy for a leading biotechnology company. Providing counsel on patent, trade secret, trademark, and copyright law.
🕒 Yesterday
Director of International Relations at IFPA advancing global presence in advocacy and policy strategies. Building relationships with international standard-setting bodies and coordinating engagements for policy alignment.